| Literature DB >> 29032755 |
Muhammad A Abdul-Ghani1,2, Amin Jayyousi3, Ralph A DeFronzo1, Nidal Asaad3, Jassim Al-Suwaidi3.
Abstract
Insulin resistance (IR) is a cardinal feature of type 2 diabetes mellitus (T2DM). It also is associated with multiple metabolic abnormalities which are known cardiovascular disease (CVD) risk factors. Thus, IR not only contributes to the development of hyperglycemia in T2DM patients, but also to the elevated CVD risk. Improving insulin sensitivity is anticipated to both lower the plasma glucose concentration and decrease CVD risk in T2DM patients, independent of glucose control. We review the molecular mechanisms and metabolic consequences of IR in T2DM patients and discuss the importance of addressing IR in the management of T2DM. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: HDL; Insulin resistance; LDL; cardiovascular disease; insulin sensitizers; type 2 diabetes.
Mesh:
Substances:
Year: 2019 PMID: 29032755 DOI: 10.2174/1570161115666171010115119
Source DB: PubMed Journal: Curr Vasc Pharmacol ISSN: 1570-1611 Impact factor: 2.719